Results 11 to 20 of about 12,098 (117)

Severe hemorrhage in choriocarcinoma: three scenarios and treatment strategies [PDF]

Gynecologic Oncology Reports
Introduction: Massive hemorrhage originating from the primary tumor site or metastases is a feared complication of choriocarcinoma. We present three cases of severe hemorrhage in patients with gestational choriocarcinoma and their clinical management ...
J. Altmann, D. Dimitrova, J. Sehouli
doaj   +2 more sources

Pure Non-Gestational Choriocarcinoma: A Case Report

Acta Medica Iranica, 2023
Choriocarcinoma usually occurs in the uterine body. Non-gestational choriocarcinoma is an extremely rare malignant tumor with a poor prognosis and is difficult to distinguish from gestational choriocarcinoma.
Helena Azimi, Amir Hosein Jafarian, Behroouz Davachi, Elaheh Zandieh, Fatemeh Shirzadeh, Zohreh Yousefi   +5 more
doaj   +1 more source

A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review

Journal of Ovarian Research, 2021
Background Pure ovarian choriocarcinoma can be gestational or nongestational in origin. Nongestational pure ovarian choriocarcinoma is extremely rare and the prognosis is thought to be worse than that of the gestational type in patients with metastatic ...
Kimihiro Nishino, Eiko Yamamoto, Yoshiki Ikeda, Kaoru Niimi, Toshimichi Yamamoto, Hiroaki Kajiyama   +5 more
doaj   +1 more source

Choriocarcinoma in tubal pregnancy: A case report

Clinical Case Reports, 2023
Key Clinical Message Choriocarcinoma of the fallopian tube is extremely rare and highly susceptible to early metastasis. Clinical manifestations of ectopic pregnancy and choriocarcinoma are the same, and all patients with ectopic pregnancy should be ...
Fateme Sadat Najib, Samaneh Bahrami, Zahra Shiravani, Seyed Mohammad Amin Alavi   +3 more
doaj   +1 more source

The tumor or inflammation? a case report on primary pulmonary choriocarcinoma

Frontiers in Oncology, 2023
Choriocarcinoma is a rare malignant germ cell neoplasm with high invasiveness, the majority of which are pregnancy-related, and the female genital tract is the most prevalent site of the disease.
Na Wang, Nan Zhang, Xinyue Zhang, Yuanyuan Wang, Yajie Fu, Lingfei Guo, Changhu Liang, Mengru Yu   +7 more
doaj   +1 more source

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells

BMC Cancer, 2020
Background Soluble Fms-like tyrosine kinase-1 (sFLT1) as an anti-angiogenic factor is abundantly expressed in placental trophoblasts. Choriocarcinoma, a malignant tumor derived from trophoblasts, is known to be highly angiogenic and metastatic.
Tadashi Sasagawa, Atsushi Jinno-Oue, Takeshi Nagamatsu, Kazuki Morita, Tetsushi Tsuruga, Mayuyo Mori-Uchino, Tomoyuki Fujii, Masabumi Shibuya   +7 more
doaj   +1 more source

Clinical features of a Chinese female nongestational choriocarcinoma cohort: a retrospective study of 37 patients

Orphanet Journal of Rare Diseases, 2020
Background Choriocarcinoma is a rare malignant neoplasm, which is classified as either gestational choriocarcinoma or nongestational choriocarcinoma. The purpose of this study was to examine the clinical characteristics of Chinese female nongestational ...
Yuming Shao, Yang Xiang, Fang Jiang, Boju Pan, Xirun Wan, Junjun Yang, Fengzhi Feng, Tong Ren, Jun Zhao   +8 more
doaj   +1 more source

Primary mediastinal choriocarcinoma in an 18‐year‐old male with pulmonary and brain metastasis: A case report

The Clinical Respiratory Journal, 2023
Primary mediastinal choriocarcinoma, also known as non‐pregnant choriocarcinoma, is a rare malignancy unrelated to pregnancy, with a higher incidence in males.
Hanlin Wang, Xiu Chen, Renquan Zhang
doaj   +1 more source

Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma

Biomedicines, 2021
The human placenta shares properties with solid tumors, such as rapid growth, tissue invasion, cell migration, angiogenesis, and immune evasion. However, the mechanisms that drive the evolution from premalignant proliferative placental diseases—called ...
Constance Collet, Jonathan Lopez, Christophe Battail, Fabienne Allias, Mojgan Devouassoux-Shisheboran, Sophie Patrier, Nicolas Lemaitre, Touria Hajri, Jérôme Massardier, Benoit You, François Mallet, François Golfier, Nadia Alfaidy, Pierre-Adrien Bolze   +13 more
doaj   +1 more source

Prognostic Nomograms and Scoring System: Novel Approaches to Forecast Overall Survival and Cancer-Specific Survival in Patients With Testicular Cancer. [PDF]

Cancer Med
ABSTRACT Objectives To develop efficacious assessment tools to individualize the evaluation of overall survival (OS) and cancer‐specific survival (CSS) in patients with testicular cancer. Methods A total of 30,689 patients diagnosed with testicular cancer between 2004 and 2021 were selected from the Surveillance, Epidemiology, and End Results database.
Huang X, Zhu L, Sun M, Zhou Y, Ding Y, Lin C.   +5 more
europepmc   +2 more sources